111 related articles for article (PubMed ID: 25030555)
1. Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis C.
Miyoshi K; Ikebuchi Y; Ishida C; Okamoto K; Murawaki Y
Intern Med; 2014; 53(14):1461-8. PubMed ID: 25030555
[TBL] [Abstract][Full Text] [Related]
2. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease.
Okamoto K; Mimura K; Murawaki Y; Yuasa I
J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221
[TBL] [Abstract][Full Text] [Related]
3. Control of progression towards liver fibrosis and hepatocellular carcinoma by SOCS3 polymorphisms in chronic HCV-infected patients.
Jadid FZ; Chihab H; Alj HS; Elfihry R; Zaidane I; Tazi S; Badre W; Marchio A; El Filali KM; Tahiri M; Saile R; Pineau P; Ezzikouri S; Benjelloun S
Infect Genet Evol; 2018 Dec; 66():1-8. PubMed ID: 30172885
[TBL] [Abstract][Full Text] [Related]
4. Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis.
Kovalenko E; Tacke F; Gressner OA; Zimmermann HW; Lahme B; Janetzko A; Wiederholt T; Berg T; Müller T; Trautwein C; Gressner AM; Weiskirchen R
J Viral Hepat; 2009 Sep; 16(9):612-20. PubMed ID: 19243500
[TBL] [Abstract][Full Text] [Related]
5. Functional gene polymorphisms of interleukin-10 are associated with liver disease progression in Japanese patients with hepatitis C virus infection.
Ishida C; Ikebuchi Y; Okamoto K; Murawaki Y
Intern Med; 2011; 50(7):659-66. PubMed ID: 21467695
[TBL] [Abstract][Full Text] [Related]
6. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
[TBL] [Abstract][Full Text] [Related]
7. The genotypes of IL-1 beta and MMP-3 are associated with the prognosis of HCV-related hepatocellular carcinoma.
Okamoto K; Ishida C; Ikebuchi Y; Mandai M; Mimura K; Murawaki Y; Yuasa I
Intern Med; 2010; 49(10):887-95. PubMed ID: 20467172
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
[TBL] [Abstract][Full Text] [Related]
9. Interferon-γ and Interleukin-10 Gene Polymorphisms are not Predictors of Chronic Hepatitis C (Genotype-4) Disease Progression.
Bahgat NA; Kamal MM; Abdelaziz AO; Mohye MA; Shousha HI; ahmed MM; Elbaz TM; Nabil MM
Asian Pac J Cancer Prev; 2015; 16(12):5025-30. PubMed ID: 26163635
[TBL] [Abstract][Full Text] [Related]
10. Association of TIMP-1 and TIMP-2 gene polymorphisms with progression of liver fibrosis in patients with type C chronic liver disease.
Ikebuchi Y; Ishida C; Okamoto K; Murawaki Y
Biochem Genet; 2013 Aug; 51(7-8):564-74. PubMed ID: 23563628
[TBL] [Abstract][Full Text] [Related]
11. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
12. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease.
Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM
Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365
[TBL] [Abstract][Full Text] [Related]
14. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer.
Silvestri L; Sonzogni L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Leveri M; Cividini A; Mondelli MU; Civardi E; Silini EM
Int J Cancer; 2003 Apr; 104(3):310-7. PubMed ID: 12569554
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.
Gewaltig J; Mangasser-Stephan K; Gartung C; Biesterfeld S; Gressner AM
Clin Chim Acta; 2002 Feb; 316(1-2):83-94. PubMed ID: 11750277
[TBL] [Abstract][Full Text] [Related]
16. Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 Patients.
Bader El Din NG; Anany MA; Dawood RM; Ibrahim MK; El-Shenawy R; El Abd YS; El Awady MK
Viral Immunol; 2015 Nov; 28(9):509-16. PubMed ID: 26505957
[TBL] [Abstract][Full Text] [Related]
17. [Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers].
Samokhodskaia LM; Starostina EE; Yarovaya EB; Krasnova TN; Mukhin NA; Tkachuk VA; Sadovnichy VA
Vestn Ross Akad Med Nauk; 2015; (6):651-61. PubMed ID: 27093792
[TBL] [Abstract][Full Text] [Related]
18. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.
El-Bassiouni NE; Nosseir MM; Madkour ME; Zoheiry MM; Bekheit IW; Ibrahim RA; Ibrahim IM; El Bassiouny AE
Mol Biol Rep; 2012 Jun; 39(6):6843-50. PubMed ID: 22318548
[TBL] [Abstract][Full Text] [Related]
19. Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.
Abbas Z; Moatter T; Hussainy A; Jafri W
World J Gastroenterol; 2005 Nov; 11(42):6656-61. PubMed ID: 16425360
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin gene polymorphism as a genetic biomarker for prediction of therapy induced clearance in Egyptian chronic HCV patients.
Hamdy M; Kassim SK; Khairy E; Maher M; Mansour KA; Albreedy AM
Gene; 2018 Apr; 649():74-79. PubMed ID: 29374597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
